Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Feb 16, 2024 | Feb 20, 2024 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.62 | $35,405 | -3.95% |
Jan 16, 2024 | Jan 18, 2024 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $14.47 | $23,499 | -3.30% |
Dec 13, 2023 | Dec 14, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.37 | $26,539 | -3.39% |
Nov 30, 2023 | Dec 01, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $12.57 | $223,755 | -28.15% |
Oct 30, 2023 | Oct 31, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $12.02 | $16,909 | -2.19% |
Jun 16, 2023 | Jun 21, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $14.4 | $17,829 | -2.08% |
Feb 16, 2023 | Feb 17, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.1 | $17,500 | -1.95% |
Jan 17, 2023 | Jan 19, 2023 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $21.24 | $34,050 | -3.21% |
Jun 16, 2022 | Jun 21, 2022 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $10.75 | $14,093 | -2.58% |
Feb 16, 2022 | Feb 18, 2022 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $9.05 | $10,371 | -2.30% |
Jan 22, 2020 | Jan 24, 2020 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $67.18 | $2M | -61.36% |
Sep 19, 2019 | Sep 23, 2019 | Martin Daniel C. Chief Commercial Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $35.56 | $106,688 | -15.00% |
- 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.